Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Multiple Myeloma × Observation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 3 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Osteoporosis 1 Oropharyngeal Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Hypertension 1 Hypercholesterolemia 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diabetes Mellitus 1 Cushing Syndrome 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Dexamethasone 29 Cyclophosphamide 23 Melphalan 21 Specimen Handling 18 Biopsy 18 Bortezomib 16 Filgrastim 13 Calcium Dobesilate 13 Magnetic Resonance Spectroscopy 12 Lenalidomide 12 fludarabine phosphate 10 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Prednisone 9 sargramostim 8 dexamethasone acetate 8 dexamethasone 21-phosphate 8 auricularum 8 Thalidomide 8 Doxorubicin 7 fludarabine 6 carfilzomib 6 Interferon-alpha 6 Busulfan 6 ixazomib 5 trametinib 4 Tacrolimus 4 Rituximab 4 Radiotherapy 4 Etoposide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00075829 2021-11-01

BMT CTN 0102

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

710 enrolled 19 charts

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡